Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIBA PHARMS CUTTING 350-450 JOBS WITH SALES FORCE TAKING MAIN BLOW

Executive Summary

CIBA PHARMS CUTTING 350-450 JOBS WITH SALES FORCE TAKING MAIN BLOW in the company's latest downsizing. Ciba Pharmaceuticals announced the restructuring April 14. The company will cut the size of the Ciba U.S. division's work force of approximately 4,600 by 7.6% to 9.8% to between roughly 4,250 and 4,150. The company said employees would be informed of their job losses "no later than mid-July" and that decisions as to who to cut would be made by a "special steering committee" that is being formed. The committee will also look at job transition options.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024335

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel